Home › Geographic Atrophy › Pennsylvania › Philadelphia
Geographic Atrophy clinical trials in Philadelphia, PA
4 studies for Geographic Atrophy are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
RecruitingPhase 3
- Mid Atlantic Retina, Wills Eye Hospital, Philadelphia
- Vision Research Solutions - the Eye Institute, Philadelphia
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
RecruitingPhase 2
- Mid Atlantic Retina, Philadelphia
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
RecruitingPhase 1
- Mid-Atlantic Retina, Philadelphia
High Resolution Retinal Imaging
RecruitingObservational studyHealthy volunteers welcome
- University of Pennsylvania, Philadelphia
Geographic Atrophy trials in other cities
- Reno, NV8 studies
- Dallas, TX8 studies
- Austin, TX7 studies
- Santa Monica, CA7 studies
- Cleveland, OH6 studies
- Naperville, IL6 studies
- The Woodlands, TX6 studies
- Baltimore, MD6 studies
- Houston, TX6 studies
- St. Louis, MO5 studies
- Washington, DC5 studies
- Spokane, WA5 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.